These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 25763406)

  • 1. The Role of Metformin in Metabolic Disturbances during Pregnancy: Polycystic Ovary Syndrome and Gestational Diabetes Mellitus.
    Rojas J; Chávez-Castillo M; Bermúdez V
    Int J Reprod Med; 2014; 2014():797681. PubMed ID: 25763406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of metformin during pregnancy in women with gestational diabetes mellitus or polycystic ovary syndrome: a systematic review.
    Lautatzis ME; Goulis DG; Vrontakis M
    Metabolism; 2013 Nov; 62(11):1522-34. PubMed ID: 23886298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gestational diabetes mellitus risk factors in women with polycystic ovary syndrome (PCOS).
    Ashrafi M; Sheikhan F; Arabipoor A; Hosseini R; Nourbakhsh F; Zolfaghari Z
    Eur J Obstet Gynecol Reprod Biol; 2014 Oct; 181():195-9. PubMed ID: 25150960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin therapy before conception versus throughout the pregnancy and risk of gestational diabetes mellitus in women with polycystic ovary syndrome: a systemic review, meta-analysis and meta-regression.
    Bidhendi Yarandi R; Behboudi-Gandevani S; Amiri M; Ramezani Tehrani F
    Diabetol Metab Syndr; 2019; 11():58. PubMed ID: 31367235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of metformin use in pregnant patients with polycystic ovary syndrome.
    Kumar P; Khan K
    J Hum Reprod Sci; 2012 May; 5(2):166-9. PubMed ID: 23162354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can metformin reduce the incidence of gestational diabetes mellitus in pregnant women with polycystic ovary syndrome? Prospective cohort study.
    Khattab S; Mohsen IA; Aboul Foutouh I; Ashmawi HS; Mohsen MN; van Wely M; van der Veen F; Youssef MA
    Gynecol Endocrinol; 2011 Oct; 27(10):789-93. PubMed ID: 21247239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does continuous use of metformin throughout pregnancy improve pregnancy outcomes in women with polycystic ovarian syndrome?
    Nawaz FH; Khalid R; Naru T; Rizvi J
    J Obstet Gynaecol Res; 2008 Oct; 34(5):832-7. PubMed ID: 18834342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin action in women with polycystic ovary syndrome and its relation to gestational diabetes.
    de Wilde MA; Goverde AJ; Veltman-Verhulst SM; Eijkemans MJ; Franx A; Fauser BC; Koster MP
    Hum Reprod; 2015 Jun; 30(6):1447-53. PubMed ID: 25840428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preconception predictors of gestational diabetes: a multicentre prospective cohort study on the predominant complication of pregnancy in polycystic ovary syndrome.
    de Wilde MA; Veltman-Verhulst SM; Goverde AJ; Lambalk CB; Laven JS; Franx A; Koster MP; Eijkemans MJ; Fauser BC
    Hum Reprod; 2014 Jun; 29(6):1327-36. PubMed ID: 24777850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pregnancy complications and glucose intolerance in women with polycystic ovary syndrome.
    Sawada M; Masuyama H; Hayata K; Kamada Y; Nakamura K; Hiramatsu Y
    Endocr J; 2015; 62(11):1017-23. PubMed ID: 26370557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Should insulin-sensitizing drugs be used in the treatment of polycystic ovary syndrome?
    Cheang KI; Nestler JE
    Reprod Biomed Online; 2004 Apr; 8(4):440-7. PubMed ID: 15149568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic parameters and perinatal outcomes of gestational diabetes mellitus in women with polycystic ovary syndrome.
    Li G; Fan L; Zhang L; Zhang W; Huang X
    J Perinat Med; 2010 Mar; 38(2):141-6. PubMed ID: 20146658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pregnancy outcomes and the effect of metformin treatment in women with polycystic ovary syndrome: an overview.
    Ghazeeri GS; Nassar AH; Younes Z; Awwad JT
    Acta Obstet Gynecol Scand; 2012 Jun; 91(6):658-78. PubMed ID: 22375613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gestational diabetes mellitus among Norwegian women with polycystic ovary syndrome: prevalence and risk factors according to the WHO and the modified IADPSG criteria.
    Helseth R; Vanky E; Salvesen O; Carlsen SM
    Eur J Endocrinol; 2013 Jul; 169(1):65-72. PubMed ID: 23636445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metformin during Pregnancy: Effects on Offspring Development and Metabolic Function.
    Jorquera G; Echiburú B; Crisosto N; Sotomayor-Zárate R; Maliqueo M; Cruz G
    Front Pharmacol; 2020; 11():653. PubMed ID: 32625081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin therapy throughout pregnancy reduces the development of gestational diabetes in women with polycystic ovary syndrome.
    Glueck CJ; Wang P; Kobayashi S; Phillips H; Sieve-Smith L
    Fertil Steril; 2002 Mar; 77(3):520-5. PubMed ID: 11872206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-sensitizing agents: use in pregnancy and as therapy in polycystic ovary syndrome.
    Checa MA; Requena A; Salvador C; Tur R; Callejo J; Espinós JJ; Fábregues F; Herrero J;
    Hum Reprod Update; 2005; 11(4):375-90. PubMed ID: 15878899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin for preventing gestational diabetes in women with polycystic ovarian syndrome.
    Ainuddin JA; Kazi S; Aftab S; Kamran A
    J Coll Physicians Surg Pak; 2015 Apr; 25(4):237-41. PubMed ID: 25899185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin administration during pregnancy tends to reduce the risk of gestational diabetes mellitus and improve pregnancy outcomes in previously infertile women with polycystic ovary syndrome who become pregnant.
    Liu H; Liu Y; Wei C; Zhang S; Xu Y
    Ir J Med Sci; 2024 Jul; ():. PubMed ID: 39030462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin: an old medication of new fashion: evolving new molecular mechanisms and clinical implications in polycystic ovary syndrome.
    Diamanti-Kandarakis E; Christakou CD; Kandaraki E; Economou FN
    Eur J Endocrinol; 2010 Feb; 162(2):193-212. PubMed ID: 19841045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.